TW201707681A - Anhydrous powder type cosmetic composition - Google Patents
Anhydrous powder type cosmetic composition Download PDFInfo
- Publication number
- TW201707681A TW201707681A TW105120624A TW105120624A TW201707681A TW 201707681 A TW201707681 A TW 201707681A TW 105120624 A TW105120624 A TW 105120624A TW 105120624 A TW105120624 A TW 105120624A TW 201707681 A TW201707681 A TW 201707681A
- Authority
- TW
- Taiwan
- Prior art keywords
- cosmetic composition
- powder
- composition according
- anhydrous powder
- dosage form
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
- A61K8/022—Powders; Compacted Powders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/895—Polysiloxanes containing silicon bound to unsaturated aliphatic groups, e.g. vinyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
Description
本發明提供一種無水粉末劑型化妝品組合物。The present invention provides a water-free powder type cosmetic composition.
本申請要求於2015年6月30日向韓國專利局提交的韓國專利申請第10-2015-0093767號的申請日的利益，其全部內容包含於本說明書中。The present application claims the benefit of the filing date of the Korean Patent Application No. 10-2015-0093767, filed on Jun. 30, 2015, the entire contents of which is incorporated herein.
對於含有粉末的化妝品，當適用於皮膚時，起到改善膚色，並且防止毛孔、皺紋、皮膚問題等的同時，將肌膚加強至均勻的狀態等的作用。這種含有粉末的化妝品可以製備成多種劑型，在乳化劑型的情況下，由於使用於均勻地分散油和水的乳化劑，因此存在長時間塗抹時持久性下降的問題，並且乳化劑還存在對皮膚造成刺激的問題。When it is applied to the skin, it is effective in improving the skin tone and preventing pores, wrinkles, skin problems, and the like, and strengthening the skin to a uniform state. The powder-containing cosmetic can be prepared into a plurality of dosage forms. In the case of an emulsifier type, since it is used for uniformly dispersing an oil and water emulsifier, there is a problem that the durability is lowered when applied for a long period of time, and the emulsifier is still present. Skin causes irritation.
此外，在無水劑型的情況下，為了提高吸油力而增加揮發性油的含量時，由於劑型不穩定，從而存在劑型分離的問題。Further, in the case of the anhydrous dosage form, when the content of the volatile oil is increased in order to increase the oil absorption force, there is a problem that the dosage form is separated because the dosage form is unstable.
因此，要求開發一種吸油力優異的同時，劑型穩定的無水粉末劑型。Therefore, it is required to develop an anhydrous powder dosage form which is excellent in oil absorption and stable in dosage form.
要解決的技術問題Technical problem to be solved
本發明欲提供一種無水粉末劑型化妝品組合物，所述組合物具有優異的吸油力，因此皮脂吸收力及妝容持久力優異的同時，劑型穩定性優異。The present invention is intended to provide a water-free powder type cosmetic composition which has excellent oil absorption power and is excellent in sebum absorption power and makeup endurance, and excellent in formulation stability.
技術手段Technical means
本發明提供一種無水粉末劑型化妝品組合物，所述組合物包括矽彈性體凝膠；包含聚二甲基矽氧烷/乙烯基聚二甲基矽氧烷交聯聚合物•二氧化矽的矽彈性體粉末；包含乙烯基聚二甲基矽氧烷/聚甲基矽氧烷矽倍半氧烷交聯聚合物的矽樹脂粉末；矽油；以及矽膠劑。The present invention provides a water-free powder type cosmetic composition comprising a ruthenium elastomer gel; a ruthenium comprising polydimethyl methoxy oxane/vinyl polydimethyl siloxane cross-linked polymer • cerium oxide Elastomer powder; an anthraquinone resin powder comprising a vinyl polydimethyl siloxane/polymethyl decane sesquioxane cross-linking polymer; an eucalyptus oil; and a sizing agent.
發明效果Effect of the invention
本發明的無水粉末劑型化妝品組合物對皮膚所分泌的皮脂、汗等油分的吸收力優異，並且作為無水劑型，沒有使用用於均勻地分散油和水的乳化劑，因此，不會因長時間的塗抹而使持久性降低，並且不對皮膚造成刺激。The anhydrous powder type cosmetic composition of the present invention is excellent in absorbance of oil such as sebum and sweat secreted by the skin, and as an anhydrous dosage form, an emulsifier for uniformly dispersing oil and water is not used, and therefore, it is not caused by a long time. The application reduces the durability and does not cause irritation to the skin.
本發明的無水粉末劑型化妝品組合物可大量含有提高吸油力的矽油，而且不會因大量含有的矽油使劑型分離，因此劑型穩定性優異。The anhydrous powder type cosmetic composition of the present invention can contain a large amount of eucalyptus oil which improves oil absorption, and does not separate the dosage form by a large amount of eucalyptus oil, so that the formulation stability is excellent.
本發明提供一種無水粉末劑型化妝品組合物。下面，將對本發明的無水粉末劑型化妝品組合物進行具體說明。The present invention provides a water-free powder type cosmetic composition. Hereinafter, the anhydrous powder form-type cosmetic composition of the present invention will be specifically described.
本發明中，對於組合物的各組成成分的含量，在總組成成分的含量的和超過100重量%的範圍內限制其上限。In the present invention, the upper limit of the content of each component of the composition is limited in a range in which the sum of the contents of the total constituent components exceeds 100% by weight.
本說明書中提及的化合物的名稱，如果沒有其它特別的說明，則表示符合美國化妝品協會（Cosmetic，Toiletry and Fragrance Association，CTFA）所發行的國際化妝品成分詞典（International Cosmetic Ingredient Dictionary，ICID）中登載的國際化妝品原料（International Nomenclature Cosmetic Ingredient，INCI）命名（Name）的化合物，如果INCI Name中不存在該名稱，則表示根據國際純粹與應用化學聯合會（International Union of Pure and Applied Chemistry, IUPAC）所制定的IUPAC命名法的化合物，如果不存在根據IUPAC命名法的化合物，則表示與本發明的技術領域中通用的化合物的名稱相對應的化合物。The names of the compounds mentioned in this specification are not included in the International Cosmetic Ingredient Dictionary (ICID) issued by the Cosmetics and Fragrance Association (CTFA). International Nomenclature Cosmetic Ingredient (INCI) Nomenclature (Name), if the name does not exist in INCI Name, it means according to the International Union of Pure and Applied Chemistry (IUPAC) The compound of the IUPAC nomenclature which is formulated, if there is no compound according to the IUPAC nomenclature, represents a compound corresponding to the name of the compound which is common in the technical field of the present invention.
本發明中，無水粉末劑型表示組合物不含水。這表示在製備組合物時不添加水，具體而言，根據本發明的化妝品組合物中，相對於組合物總重量，水的含量為10重量%以下。In the present invention, the anhydrous powder dosage form means that the composition does not contain water. This means that water is not added in the preparation of the composition, and specifically, the cosmetic composition according to the present invention has a water content of 10% by weight or less based on the total weight of the composition.
1）矽彈性體凝膠1) 矽 elastomer gel
本發明中，矽彈性體凝膠表示將矽彈性體吸入於矽油中的凝膠，對矽彈性體和矽油的混合量沒有特別的限制。In the present invention, the 矽 elastomer gel represents a gel in which the ruthenium elastomer is sucked into the eucalyptus oil, and the amount of the ruthenium elastomer and the eucalyptus oil is not particularly limited.
本發明的一實施方式中，矽彈性體凝膠為選自環聚二甲基矽氧烷•聚二甲基矽氧烷/乙烯基聚二甲基矽氧烷交聯聚合物、環聚二甲基矽氧烷•聚二甲基矽氧烷交聯聚合物及聚二甲基矽氧烷·聚二甲基矽氧烷/乙烯基聚二甲基矽氧烷交聯聚合物中的任意一種或它們的組合。In one embodiment of the present invention, the 矽elastomer gel is selected from the group consisting of cyclopolydimethyl siloxane, polydimethyl siloxane, vinyl polydimethyl siloxane, cross-linked polymer, and cyclohexane. Any of methylidene oxide/polydimethyloxane cross-linking polymer and polydimethyloxane·polydimethyloxane/vinyl polydimethyloxane cross-linked polymer One or a combination thereof.
本發明的一實施方式中，相對於組合物總重量，矽彈性體凝膠的含量為超過0重量%且50重量%以下。In one embodiment of the present invention, the content of the 矽 elastomer gel is more than 0% by weight and 50% by weight or less based on the total weight of the composition.
2）矽彈性體粉末2) 矽 elastomer powder
本發明中，矽彈性體粉末包含聚二甲基矽氧烷/乙烯基聚二甲基矽氧烷交聯聚合物•二氧化矽。In the present invention, the cerium elastomer powder comprises polydimethyl methoxy oxane/vinyl polydimethyl decane crosslinked polymer • cerium oxide.
本發明的一實施方式中，相對於組合物總重量，矽彈性體粉末的含量為3~20重量%，較佳為3~10重量%。當矽彈性體粉末的含量少於3重量%時，隨著時間的推移，會分離出油，從而在劑型穩定性方面發生問題，當超過10重量%時，組合物不能凝聚，並且使粉末化，從而不可能形成糊狀物，因此會發生劑型製備方面的問題。相反地，當矽彈性體粉末的含量在3~20重量%的範圍內時，劑型具有流動性，粉末間具有黏滯力，而且劑型不會隨著時間的推移而發生分離或開裂，並且能夠維持穩定的狀態。In one embodiment of the present invention, the content of the cerium elastomer powder is from 3 to 20% by weight, preferably from 3 to 10% by weight, based on the total weight of the composition. When the content of the cerium elastomer powder is less than 3% by weight, the oil is separated over time, causing problems in the stability of the dosage form, and when it exceeds 10% by weight, the composition cannot be agglomerated and powdered. Thus, it is impossible to form a paste, and thus problems in preparation of a dosage form may occur. Conversely, when the content of the lanthanum elastomer powder is in the range of 3 to 20% by weight, the dosage form has fluidity, the powder has a viscous force, and the dosage form does not separate or crack over time, and Maintain a stable state.
3）矽樹脂粉末3) Resin powder
本發明中，矽樹脂粉末包含乙烯基聚二甲基矽氧烷/聚甲基矽氧烷矽倍半氧烷交聯聚合物。In the present invention, the ruthenium resin powder contains a vinyl polydimethyl siloxane/polymethyl decane sesquioxane crosslinked polymer.
本發明的一實施方式中，相對於組合物總重量，矽樹脂粉末的含量為5~25重量%，較佳為5~10重量%。當矽樹脂粉末的含量少於5重量%時，粉末間的黏滯力不足，從而發生製備時不能形成糊狀物的問題，當超過25重量%時，油會從劑型中分離，從而在劑型穩定性方面發生問題。In one embodiment of the present invention, the content of the enamel resin powder is 5 to 25% by weight, preferably 5 to 10% by weight based on the total weight of the composition. When the content of the enamel resin powder is less than 5% by weight, the viscous force between the powders is insufficient, so that the problem that the paste cannot be formed at the time of preparation occurs, and when it exceeds 25% by weight, the oil is separated from the dosage form, thereby being in the dosage form. There is a problem with stability.
4）矽油4) oyster sauce
本發明中，組合物包括矽油，並且因包括矽油，從而被矽彈性體粉末及矽樹脂粉末吸收的矽油在塗抹於皮膚後揮發，因此，矽彈性體粉末及矽樹脂粉末可以有效地吸收皮膚的皮脂、汗等油成分。In the present invention, the composition includes eucalyptus oil, and the eucalyptus oil absorbed by the enamel elastomer powder and the enamel resin powder is volatilized after being applied to the skin because of the eucalyptus oil, and therefore, the enamel elastomer powder and the enamel resin powder can effectively absorb the skin. Sebum, sweat and other oil components.
本發明的一實施方式中，矽油為選自環五聚二甲基矽氧烷•環己矽氧烷、聚二甲基矽氧烷•三矽氧烷及聚二甲基矽氧烷中的任意一種或它們的組合。In one embodiment of the present invention, the eucalyptus oil is selected from the group consisting of cyclopenta-dimethyl oxoxane, cyclohexanoxane, polydimethyl siloxane, trioxane, and polydimethyl siloxane. Any one or a combination thereof.
本發明的一實施方式中，相對於組合物總重量，矽油的含量為40~60重量%。當矽油的含量少於40重量%時，吸油能力不充分，並且粉末間的黏滯力不足，從而發生製備時不能形成糊狀物的問題，當超過60重量%時，油會從劑型中分離，從而在劑型穩定性方面發生問題。In one embodiment of the present invention, the content of the eucalyptus oil is 40 to 60% by weight based on the total weight of the composition. When the content of the eucalyptus oil is less than 40% by weight, the oil absorbing ability is insufficient, and the viscous force between the powders is insufficient, so that the problem that the paste cannot be formed at the time of preparation occurs, and when it exceeds 60% by weight, the oil is separated from the dosage form. Thus, problems occur in the stability of the dosage form.
5）矽膠劑5) Silicone glue
本發明中，組合物包括矽膠劑，從而即使含有高含量的矽油，劑型的相也不會發生分離而且使穩定化，並且能夠賦予柔和的使用感。In the present invention, the composition includes a silicone gel, so that even if a high content of emu oil is contained, the phase of the dosage form does not separate and stabilize, and can impart a soft feeling of use.
本發明的一實施方式中，矽膠劑為聚二甲基矽氧烷/PEG-10/15交聯聚合物•環五聚二甲基矽氧烷。In one embodiment of the invention, the silicone is a polydimethyl methoxyane/PEG-10/15 crosslinked polymer•cyclopentamethyl dimethyloxane.
本發明的一實施方式中，相對於組合物總重量，矽膠劑的含量為2~5重量%。當矽膠劑的含量少於2重量%時，吸油能力不充分，並且粉末間的黏滯力不足，從而發生製備時不能形成糊狀物的問題，當超過5重量%時，油會從劑型中分離，從而在劑型穩定性方面發生問題。In one embodiment of the invention, the content of the silicone agent is from 2 to 5% by weight based on the total weight of the composition. When the content of the silicone agent is less than 2% by weight, the oil absorption capacity is insufficient, and the viscous force between the powders is insufficient, so that the problem that the paste cannot be formed at the time of preparation occurs, and when it exceeds 5% by weight, the oil is from the dosage form. Separation, causing problems in formulation stability.
6）其它粉體6) Other powders
本發明的一實施方式中，組合物可以進一步包括選自二氧化鈦、雲母、聚甲基丙烯酸甲酯、聚甲基矽倍半氧烷、二氧化矽及氧化鈦、氧化鐵、聚甲基丙烯酸甲酯中的任意一種以上的粉體。粉體可以藉由反射光來改善膚色，並且防止毛孔、皺紋、皮膚問題等的同時，吸收皮脂，從而提高妝容的持久性，並且起到將肌膚加強至均勻的狀態等的作用。In an embodiment of the present invention, the composition may further comprise a selected from the group consisting of titanium dioxide, mica, polymethyl methacrylate, polymethyl sesquioxanes, cerium oxide and titanium oxide, iron oxide, polymethyl methacrylate Any one or more of the esters. The powder can improve the skin color by reflecting light, and prevent pores, wrinkles, skin problems, and the like, and absorb sebum, thereby enhancing the durability of the makeup and enhancing the skin to a uniform state.
本發明的一實施方式中，相對於組合物總重量，粉體的含量為2~25重量%。當粉體的含量少於2重量%時，不貼緊於皮膚，而產生浮粉感的等不利的使用感，當超過25重量%時，會發生製備時不能形成糊狀物的問題。In one embodiment of the present invention, the content of the powder is from 2 to 25% by weight based on the total weight of the composition. When the content of the powder is less than 2% by weight, it does not adhere to the skin, and an unpleasant feeling of use such as a floating powder is generated. When it exceeds 25% by weight, there is a problem that a paste cannot be formed at the time of preparation.
本發明的一實施方式中，化妝品組合物可以含有化妝品學或皮膚科學上可接受的載體或機制而被劑型化。這些組合物可以根據該領域具有通常知識者的方法製備。In one embodiment of the invention, the cosmetic composition may be formulated by a cosmetic or dermatologically acceptable carrier or mechanism. These compositions can be prepared according to methods of ordinary skill in the art.
此外，本發明的化妝品組合物可以含有諸如常用於化妝品的任何其它成分的在化妝品學或皮膚科學領域中通常使用的輔助劑。輔助劑可以以在化妝品學或皮膚科學領域中通常使用的量來導入。Further, the cosmetic composition of the present invention may contain an adjuvant which is generally used in the field of cosmetic or dermatological science, such as any other ingredients commonly used in cosmetics. The adjuvant can be introduced in an amount generally used in the field of cosmetic or dermatological science.
下面，為了加強對本發明的理解，將藉由實施例、比較例、試驗例等的具體的例子來進行說明。但不能解釋為用下述實施例來限定本發明，並且在本發明的範圍內，本領域技術人員可以進行常規的變化。Hereinafter, in order to enhance the understanding of the present invention, specific examples of the examples, comparative examples, test examples, and the like will be described. However, the invention is not limited by the following examples, and those skilled in the art can make conventional changes within the scope of the invention.
[製備例1] 實施例1~5及比較例1的製備[Preparation Example 1] Preparation of Examples 1 to 5 and Comparative Example 1
根據下述表1的成分，分別製備了實施例1~5及比較例1的組合物，其具體過程如下。The compositions of Examples 1 to 5 and Comparative Example 1 were prepared according to the components of Table 1 below, and the specific procedures are as follows.
表1 Table 1
1）道康寧公司（Dow Corning Corporation）/DC 1-9852 矽凝膠（SILICONE GEL）1) Dow Corning Corporation / DC 1-9852 SI Gel (SILICONE GEL)
2）道康寧公司/DC 9040 有機矽彈性體混合物（SILICONE ELASTOMER BLEND），聚二甲基矽氧烷/乙烯基聚二甲基矽氧烷交聯聚合物（96重量%）及二氧化矽（4重量%）2) Dow Corning Corporation / DC 9040 organo-elastomer elastomer mixture (SILICONE ELASTOMER BLEND), polydimethyl methoxy oxane / vinyl polydimethyl methoxane cross-linked polymer (96% by weight) and cerium oxide (4 weight%)
3）金剛化工集團（KCC CORPORATION）/SM9120G（SeraSilk EL 61）3) King Kong Chemical Group (KCC CORPORATION) / SM9120G (SeraSilk EL 61)
4）道康寧公司/Dow Corning 9701 Cosmetic Powder4) Dow Corning Company / Dow Corning 9701 Cosmetic Powder
5）信越化學工業株式會社（Shin-Etsu Chemical Co., Ltd.）/KSP-1015) Shin-Etsu Chemical Co., Ltd./KSP-101
6）道康寧公司/PMX-0345矽氧烷混合物（SILOXANE BLEND）6) Dow Corning/PMX-0345 Oxane Mixture (SILOXANE BLEND)
7）道康寧公司/XIAMETER PMX-2127 FLUID7) Dow Corning Corporation / XIAMETER PMX-2127 FLUID
8）信越化學工業株式會社/KSG-2408) Shin-Etsu Chemical Co., Ltd. / KSG-240
9）K.S.PEARL Co., Ltd./雲母（Sericite） J9) K.S.PEARL Co., Ltd./Sericite J
10）Negami Chemical Industrial Co.,Ltd./Artpearl K-7P10) Negami Chemical Industrial Co., Ltd./Artpearl K-7P
11）邁圖高新材料有限公司（Momentive Performance Materials Inc.）/Tospearl* 2000B11) Momentive Performance Materials Inc./Tospearl* 2000B
12）JGC C&C/Spherica Microbeads P-150012) JGC C&C/Spherica Microbeads P-1500
13）大東化成工業株式會社（DAITO KASEI KOGYO CO.,LTD.）/OTS-2 TIO2 CR-5013) DAITO KASEI KOGYO CO., LTD. / OTS-2 TIO2 CR-50
14）大東化成工業株式會社/OTS-2 YELLOW LLXLO14) Dadong Chemical Industry Co., Ltd. / OTS-2 YELLOW LLXLO
15）大東化成工業株式會社/OTS-2 RED R-516L15) Dadong Chemical Industry Co., Ltd. / OTS-2 RED R-516L
16）大東化成工業株式會社/OTS-2 BLACK BL-10016) Dadong Chemical Industry Co., Ltd. / OTS-2 BLACK BL-100
使用Primix公司製造的產品名為HIVIS分散攪拌機（Disper Mixer），2P-1的混合機，將成分1及4在常溫（25℃）下混合5分鐘。之後，在成分1及4的混合物中加入成分5及6後，使用混合機，分散5分鐘，在分散過程中控制溫度上升，使溫度控制為50℃以下。The ingredients 1 and 4 were mixed at room temperature (25 ° C) for 5 minutes using a mixer manufactured by Primix Corporation under the name of HIVIS Disper Mixer, 2P-1. Thereafter, the components 5 and 6 were added to the mixture of the components 1 and 4, and the mixture was dispersed for 5 minutes using a mixer, and the temperature was controlled during the dispersion to control the temperature to 50 ° C or lower.
在成分1及4~6的混合物中緩緩的投入成分2及3，並使用混合機，分散5分鐘，在分散過程中控制溫度上升，使溫度控制為50℃以下，從而分別製備了實施例1~5及比較例1的組合物。In the mixture of the components 1 and 4 to 6, the components 2 and 3 were gradually added, and the mixture was dispersed for 5 minutes using a mixer, and the temperature was controlled during the dispersion to control the temperature to 50 ° C or lower. Compositions 1 to 5 and Comparative Example 1.
[試驗例1]皮脂吸油能力的測定[Test Example 1] Determination of sebum absorption capacity
當將本發明的化妝品塗抹於皮膚時，矽樹脂粉末、矽彈性體粉末等高吸油性粉末以含有油的狀態被塗抹，因此，剛塗抹之後皮脂吸油能力會降低，然而塗抹後經過一段時間後，揮發成分發生氣化而被釋放，因此，可以使皮脂吸油能力恢復。為了確認此特性，分別將5g的實施例1~5及比較例1的組合物裝入燒杯中，並且在50℃下經過30分鐘後，如下述分別對設定為人工皮脂的辛酸/癸酸甘油三酯（InterMed公司製造、產品名為Imex MCT 60/40）進行濕潤的同時，測定吸油率。When the cosmetic of the present invention is applied to the skin, the highly oil-absorbing powder such as the resin powder or the enamel elastomer powder is applied in an oil-containing state, so that the oil absorption capacity of the sebum is lowered immediately after the application, but after a lapse of time after application The volatile component is vaporized and released, so that the sebum absorption capacity can be restored. In order to confirm this characteristic, 5 g of the compositions of Examples 1 to 5 and Comparative Example 1 were placed in a beaker, respectively, and after 30 minutes at 50 ° C, octanoic acid/capric acid glycerin set as artificial sebum was separately obtained as follows. The oil absorption rate was measured while the triester (manufactured by InterMed Co., Ltd., product name: Imex MCT 60/40) was wetted.
在5g的實施例1~5及比較例1的組合物中，分別緩緩滴入辛酸/癸酸甘油三酯（CAPRYLIC/CAPRIC TRIGLYCERIDE）的同時，測定其重量，並且在該樣品吸收辛酸/癸酸甘油三酯的過程中繼續重複上述操作。當不能繼續吸收辛酸/癸酸甘油三酯時，分別記錄各樣品所吸收的量，並根據下述式1計算皮脂吸油率。In 5 g of the compositions of Examples 1 to 5 and Comparative Example 1, the weight of the caprylic/capric acid triglyceride (CAPRYLIC/CAPRIC TRIGLY CERIDE) was gradually dropped, and the octanoic acid/癸 was absorbed in the sample. The above operation is continued in the course of acid triglyceride. When the octanoic acid/capric triglyceride could not be continuously absorbed, the amount absorbed by each sample was separately recorded, and the sebum absorption rate was calculated according to the following formula 1.
[式1][Formula 1]
皮脂吸油率（%）=該樣品的辛酸/癸酸甘油三酯（CAPRYLIC/CAPRIC TRIGLYCERIDE）的最終吸收量（單位g）/該樣品的最初重量（5g）×100（%）Sebum absorption rate (%) = final absorption of CAPRYLIC/CAPRIC TRIGLY CERIDE (in g) / initial weight of the sample (5g) × 100 (%)
對實施例1~5及比較例1的皮脂吸油率的測定結果如下述表2中所示。The measurement results of the sebum absorption ratios of Examples 1 to 5 and Comparative Example 1 are shown in Table 2 below.
表2
如上述表2中所示，可以確認實施例1~5的皮脂吸油率優異，相反，比較例1因劑型分離而不能測定皮脂吸油率。As shown in the above Table 2, it was confirmed that the sebum absorption ratios of Examples 1 to 5 were excellent. On the contrary, in Comparative Example 1, the sebum absorption rate could not be measured due to the separation of the dosage form.
[試驗例2]劑型的穩定度測定[Test Example 2] Determination of stability of dosage form
將實施例1~5及比較例1分別裝入管容器中後倒立放置，並且在55℃的溫度下放置2周以上後，將其排出並觀察該劑型的狀態。Each of Examples 1 to 5 and Comparative Example 1 was placed in a tube container, placed upside down, and left at a temperature of 55 ° C for 2 weeks or more, and then discharged and observed in the state of the dosage form.
如果根據黏度下降現象而出現單獨分離油或塗抹於皮膚時油被分離到皮膚一側的現象，則將劑型判斷為“分離”，當沒有觀察到這些問題的情況下，則判斷為“穩定”。If the oil is separated to the side of the skin when the oil is separately separated or applied to the skin according to the viscosity drop phenomenon, the dosage form is judged as "separation", and when these problems are not observed, it is judged as "stable". .
對實施例1~5及比較例1的劑型分離與否的測定結果如下述表3中所示。The measurement results of the separation of the dosage forms of Examples 1 to 5 and Comparative Example 1 are shown in Table 3 below.
表3
如上述表3中所示，可以確認根據本發明的組成的實施例1~5的劑型穩定，相反，超出本發明的組成的比較例1的劑型不穩定。As shown in the above Table 3, it was confirmed that the dosage forms of Examples 1 to 5 according to the composition of the present invention were stable, and conversely, the dosage form of Comparative Example 1 which exceeded the composition of the present invention was unstable.
[製備例2] 實施例4、6及比較例2~6的製備[Preparation Example 2] Preparation of Examples 4 and 6 and Comparative Examples 2 to 6
分別製備了實施例4、6及比較例2~6的組合物，對於其具體過程，除了根據下述表4的組成以外，採用了與製備例1相同的製備方法。The compositions of Examples 4 and 6 and Comparative Examples 2 to 6 were prepared, respectively, and the same preparation method as in Preparation Example 1 was employed except for the composition of Table 4 below.
表4 Table 4
1）~16）：與表1相同。1)~16): Same as Table 1.
8-1）道康寧公司/DC BY 11-0308-1) Dow Corning Corporation / DC BY 11-030
8-2）德國贏創工業集團（Evonik）/ABIL EM 908-2) Evonik/ABIL EM 90
8-3）信越化學工業株式會社/KF-60388-3) Shin-Etsu Chemical Co., Ltd. / KF-6038
[試驗例3] 劑型的穩定度測定[Test Example 3] Determination of stability of dosage form
將製備的實施例4、6及比較例3至5的組合物分別填充於管容器中，並且在55℃下保管3天。之後，將保管3天的各組合物塗抹於皮膚上，並進行拍攝。此外，將這些組合物在55℃下保管14天後，將各組合物塗抹於皮膚上，然後進行拍攝，並且示於第1至3圖中。The prepared compositions of Examples 4 and 6 and Comparative Examples 3 to 5 were each filled in a tube container, and stored at 55 ° C for 3 days. Thereafter, each composition stored for 3 days was applied to the skin and photographed. Further, after the compositions were stored at 55 ° C for 14 days, each composition was applied to the skin, and then photographed, and shown in Figures 1 to 3.
參見第1及2圖，可以確認比較例3（第1圖）、比較例4（第2圖的左側）及比較例5（第2圖的右側）的組合物中，油從劑型分離，因此劑型不穩定。Referring to Figures 1 and 2, it was confirmed that the composition of Comparative Example 3 (Fig. 1), Comparative Example 4 (left side of Fig. 2), and Comparative Example 5 (right side of Fig. 2) were separated from the dosage form. The dosage form is unstable.
相反地，參見第3圖，可以確認實施例4（第3圖的左側）及實施例6（第3圖的右側）的組合物中，油沒有從劑型分離，因此劑型穩定。On the contrary, referring to Fig. 3, it was confirmed that the composition of Example 4 (left side of Fig. 3) and Example 6 (right side of Fig. 3) were not separated from the dosage form, and thus the dosage form was stable.
另外，將實施例6及比較例2分別裝入發膏瓶中，並在55℃的溫度下放置三天後，將其取出並暴露於空氣中，然後觀察劑型的表面是否發生開裂現象。Further, Example 6 and Comparative Example 2 were respectively placed in a cream bottle, and after being left at a temperature of 55 ° C for three days, they were taken out and exposed to the air, and then the surface of the dosage form was observed to be cracked.
參見第4圖，可以確認比較例2如左側照片所示，觀察到劑型的開裂，因此劑型不穩定。相反地，參見第5圖，可以確認實施例4如右側照片所示，沒有觀察到開裂的現象，因此劑型穩定。Referring to Fig. 4, it was confirmed that Comparative Example 2 showed cracking of the dosage form as shown in the left photograph, and thus the dosage form was unstable. On the contrary, referring to Fig. 5, it was confirmed that Example 4 showed no cracking as shown in the right photograph, and thus the dosage form was stable.
無no
第1圖是示出將比較例3在55℃下保管3天後，塗抹於皮膚並拍攝的圖。Fig. 1 is a view showing a state in which the comparative example 3 was stored at 55 ° C for 3 days, and then applied to the skin and photographed.
第2圖是示出將比較例4在55℃下保管14天後，塗抹於皮膚（左側）並拍攝的圖，並示出將比較例5在55℃下保管14天後，塗抹於皮膚（右側）並拍攝的圖。Fig. 2 is a view showing a case where the comparative example 4 was stored at 55 ° C for 14 days, and then applied to the skin (left side), and photographed, and the comparative example 5 was stored at 55 ° C for 14 days, and then applied to the skin ( Right side) and the picture taken.
第3圖是示出將實施例4在55℃下保管14天後，塗抹於皮膚（左側）並拍攝的圖，並示出將實施例6在55℃下保管14天後，將其塗抹於皮膚（右側）並拍攝的圖。Fig. 3 is a view showing the application of Example 4 to a skin (left side) after storage at 55 ° C for 14 days, and showing that Example 6 was stored at 55 ° C for 14 days, and then applied thereto. The skin (right side) and the picture taken.
第4圖是示出將實施例6裝入發膏瓶中，並在55℃的溫度下放置3天後，將其取出並暴露於空氣中，然後拍攝劑型（右側）的圖。Fig. 4 is a view showing that Example 6 was placed in a cream bottle and left at a temperature of 55 ° C for 3 days, taken out and exposed to the air, and then the dosage form (right side) was photographed.
第5圖是示出將比較例2裝入發膏瓶中，並在55℃的溫度下放置3天後，將其取出並暴露於空氣中，然後拍攝劑型（左側）的圖。Fig. 5 is a view showing that Comparative Example 2 was placed in a cream bottle and left at a temperature of 55 ° C for 3 days, taken out and exposed to the air, and then the dosage form (left side) was photographed.
Claims (8)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020150093767A KR102405999B1 (en) | 2015-06-30 | 2015-06-30 | Anhydrous powder type comsmetic composition |
| KR10-2015-0093767 | 2015-06-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201707681A true TW201707681A (en) | 2017-03-01 |
| TWI705830B TWI705830B (en) | 2020-10-01 |
Family
ID=57608672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW105120624A TWI705830B (en) | 2015-06-30 | 2016-06-29 | Anhydrous powder type cosmetic composition |
Country Status (5)
| Country | Link |
|---|---|
| KR (1) | KR102405999B1 (en) |
| CN (1) | CN107979997A (en) |
| HK (1) | HK1254327A1 (en) |
| TW (1) | TWI705830B (en) |
| WO (1) | WO2017003139A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108542802A (en) * | 2018-04-16 | 2018-09-18 | 广州市宝琳化妆品有限公司 | A kind of transparent muffin of cosmetic and preparation method thereof |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110996899A (en) * | 2017-07-18 | 2020-04-10 | 阿玛特拉苏生命科学有限责任公司 | Anti-scuffing gel compositions |
| KR101944198B1 (en) * | 2017-12-18 | 2019-01-30 | 김양지 | Booklet type color cosmetics classified by 9 types of personal color |
| KR102321529B1 (en) * | 2019-06-17 | 2021-11-04 | 코스맥스 주식회사 | Anhydrous Eyebrow Make-up Cosmetic Composition |
| KR20210067243A (en) * | 2019-11-29 | 2021-06-08 | (주)아모레퍼시픽 | Cosmetic composition for lip |
| US20220362130A1 (en) * | 2021-04-30 | 2022-11-17 | L'oreal | Compositions and methods for treating keratin fibers |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100211419B1 (en) | 1997-03-14 | 1999-08-02 | 서경배 | A solid emulsion type cosmetic compositions being applied in T-zone and containing the silicone resin powder |
| US6475500B2 (en) | 2000-07-10 | 2002-11-05 | The Procter & Gamble Company | Anhydrous cosmetic compositions |
| KR101221153B1 (en) | 2006-11-27 | 2013-01-11 | (주)아모레퍼시픽 | Make-up cosmetic composition of oil-dispersed cake type with high elasticity and the method of preparing thereof |
| JP5779347B2 (en) * | 2009-12-24 | 2015-09-16 | 東レ・ダウコーニング株式会社 | Copolymer having carbosiloxane dendrimer structure, and composition and cosmetic containing the same |
| KR101269405B1 (en) * | 2011-03-11 | 2013-05-30 | 코스맥스 주식회사 | Make-up cosmetic composition containing silicone elastomer |
| JP5908699B2 (en) * | 2011-10-31 | 2016-04-26 | 富士フイルム株式会社 | Cosmetics |
| JP5741519B2 (en) * | 2012-04-25 | 2015-07-01 | 信越化学工業株式会社 | Oil makeup cosmetics |
-
2015
- 2015-06-30 KR KR1020150093767A patent/KR102405999B1/en active IP Right Grant
-
2016
- 2016-06-24 WO PCT/KR2016/006760 patent/WO2017003139A1/en active Application Filing
- 2016-06-24 CN CN201680034564.4A patent/CN107979997A/en active Pending
- 2016-06-29 TW TW105120624A patent/TWI705830B/en not_active IP Right Cessation
-
2018
- 2018-10-17 HK HK18113297.3A patent/HK1254327A1/en unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108542802A (en) * | 2018-04-16 | 2018-09-18 | 广州市宝琳化妆品有限公司 | A kind of transparent muffin of cosmetic and preparation method thereof |
| CN108542802B (en) * | 2018-04-16 | 2019-07-19 | 广州市宝琳化妆品有限公司 | A kind of transparent muffin of cosmetic and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017003139A1 (en) | 2017-01-05 |
| TWI705830B (en) | 2020-10-01 |
| KR102405999B1 (en) | 2022-06-08 |
| HK1254327A1 (en) | 2019-07-19 |
| KR20170003291A (en) | 2017-01-09 |
| CN107979997A (en) | 2018-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW201707681A (en) | Anhydrous powder type cosmetic composition | |
| JP4757950B2 (en) | Lip cosmetic | |
| TWI617322B (en) | Sunscreen cosmetics | |
| CN103371930B (en) | Oil base cosmetic cosmetic product | |
| CN106456510B (en) | Replenishing water and preserving moisture bar-like cosmetic | |
| CN107638302B (en) | Water droplet solid type antiultraviolet cosmetic composition | |
| JP2009203212A (en) | Pasty oil-based cosmetic composition | |
| TW201717895A (en) | Fluid type oil-dispersed eye make-up composition | |
| JP2010111625A (en) | Sunscreen cosmetic | |
| CN105916490B (en) | Lip applies some make up composition | |
| JP2008106049A (en) | Oily-liquid lip cosmetic | |
| KR20130117151A (en) | Thermal stable solid formulation of water in oil type emulsion | |
| TW202011928A (en) | Two-layered oil-based cosmetic | |
| KR20060073725A (en) | Cosmetic composition of dispersion type liquid foundation and a method of preparing thereof | |
| JP5955048B2 (en) | Water-in-oil emulsified cosmetic | |
| JP6441528B1 (en) | Composition for makeup base | |
| JP2002087929A (en) | Gel-like composition and cosmetic product comprising the same | |
| JP2015193564A (en) | makeup cosmetics | |
| KR102047875B1 (en) | Make-up cosmetic composition of oil-dispersed liquid type | |
| KR20130083154A (en) | Lip cosmetic composition containing dicaprylyl carbonate | |
| JP5345369B2 (en) | Sunscreen cosmetics | |
| JP2011026234A (en) | Cosmetic composition | |
| JP2010070459A (en) | Method for producing oily solid cosmetic, and the oily solid cosmetic | |
| JP2010024163A (en) | Oily lip coat | |
| WO2020075792A1 (en) | External preparation for concealing roughness |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |